A Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Circadin to Alleviate Sleep Disturbances in Children With Neurodevelopmental Disabilities
Phase of Trial: Phase III
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Melatonin (Primary)
- Indications Developmental disabilities; Sleep disorders
- Focus Registrational; Therapeutic Use
- Sponsors NEURIM Pharmaceuticals
- 16 Nov 2016 Status changed from active, no longer recruiting to completed, as per a Neurim Pharmaceuticals media release.
- 16 Nov 2016 This trial was carried out under EU-PIP and US-FDA IND, as reported by a Neurim Pharmaceuticals media release.
- 02 Nov 2016 Results from this study will be presented at upcoming medical congresses, as reported by a Neurim Pharmaceuticals Media Release.